| Identification | Back Directory | [Name]
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[(2-hydroxyethyl)amino]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- | [CAS]
2643375-86-2 | [Synonyms]
RET-IN-15
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-[(2-hydroxyethyl)amino]-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]- | [Molecular Formula]
C27H28N8O2 | [MOL File]
2643375-86-2.mol | [Molecular Weight]
496.56 |
| Hazard Information | Back Directory | [Uses]
RET-IN-15 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021115457A1 compound 51. RET-IN-15 can be used for the research of cancer[1]. | [References]
[1] Chen HM, et, al. Pyrazolo[1,5-a]pyridine compound, preparation method therefor and use thereof. WO2021115457A1. |
|
|